Coenzyme Q10 reduces the toxicity of rotenone in neuronal cultures by preserving the mitochondrial membrane potential

BioFactors

Volumn 18, Issue 1-4, 2003, Pages 65-72

  Menke, T ^a   Gille, G ^b   Reber, F ^b   Janetzky, B ^b   Andler, W ^a   Funk, R H W ^b   Reichmann, H ^b  

^a UNIVERSITY OF WITTEN HERDECKE   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

Apoptosis; Coenzyme Q10; JC 1; Mitochondrial membrane potential; SH SY5Y

Indexed keywords

FLUORESCENT DYE; JC 1; NEUROPROTECTIVE AGENT; ROTENONE; SANOMIT; UBIDECARENONE; UNCLASSIFIED DRUG; 5,5',6,6' TETRACHLORO 1,1',3,3' TETRAETHYLBENZIMIDAZOLOCARBOCYANINE; 5,5',6,6'-TETRACHLORO-1,1',3,3'-TETRAETHYLBENZIMIDAZOLOCARBOCYANINE; ANTIOXIDANT; BENZIMIDAZOLE DERIVATIVE; CARBOCYANINE; DRUG DERIVATIVE; ENZYME INHIBITOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINONE;

APOPTOSIS; CELL PROTECTION; CONFERENCE PAPER; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENERGY METABOLISM; FLUORESCENCE; HUMAN; HUMAN CELL; MEMBRANE DEPOLARIZATION; MEMBRANE POTENTIAL; MICROSCOPY; MITOCHONDRIAL MEMBRANE; MITOCHONDRIAL RESPIRATION; NERVE CELL CULTURE; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RESPIRATORY CHAIN; VIDEO ENHANCED MICROSCOPY; ARTICLE; CELL CULTURE; CELL MEMBRANE POTENTIAL; DRUG ANTAGONISM; DRUG EFFECT; ELECTRON TRANSPORT; METABOLISM; MITOCHONDRION; NERVE CELL; NEUROBLASTOMA; ULTRASTRUCTURE;

ANTIOXIDANTS; APOPTOSIS; BENZIMIDAZOLES; CARBOCYANINES; CYTOPROTECTION; ELECTRON TRANSPORT; ELECTRON TRANSPORT COMPLEX I; ENERGY METABOLISM; ENZYME INHIBITORS; FLUORESCENT DYES; HUMANS; MEMBRANE POTENTIALS; MITOCHONDRIA; NEUROBLASTOMA; NEURONS; ROTENONE; TUMOR CELLS, CULTURED; UBIQUINONE;

EID: 0346158468     PISSN: 09516433     EISSN: None     Source Type: Journal    
DOI: 10.1002/biof.5520180208     Document Type: Conference Paper

References (24)

1. D.G. Green and J.C. Reed, Mitochondria and apoptosis, Science 281 (1998), 1309-1312.
2. W.G. Tatton and C.W. Olanow, Apoptosis in neurodegenerative diseases: the role of mitochondria, Biochim. Biophys. Acta 1410 (1999), 195-213.
3. D.G. Wallace, Mitochondrial diseases in man and mouse, Science 283 (1999), 1482-1487.
4. L. Ernster and G. Dallner, Biochemical, physical and medical aspects of ubiquinone functions, Biochim. Biophys. Acta 1271 (1995), 195-204.
5. 10, Clin. Invest. 71 (1993), 55-59.
6. 10: Absorption, antioxidative properties, determinants and plasma level, Free Rad. Res. 36 (2002), 389-397.
7. 10 in the plasma membrane, Mol. Asp. Med. 18 (1997), S7-S13.
8. R.E. Beyer, J. Segure-Aguilar, S. Di bernardo, M. Cavazonni, R. Fato, D. Fiorentini M.C. Galli, M. Sethi, L. Landi and G. Lenaz, The role of DT-diaphorase in the maintenace of the reduced antioxidant form of coenzyme q in membrane systems, Proc. Natl. Acad. Sci. USA 93 (1996), 2528-2532.
9. 10 as a possible treatment for neurodegenerative diseases, Free Radic. Res. 36 (2002), 455-460.
10. R.H.W. Funk, F. Nagel, F. Wonka, H.E. Krinke, F. Gölfert and A. Hofer, Effects of heat shock on the functional morphology of cell organelles observed by video-enhanced microscopy, Anat. Rec. 255 (1999), 458-464.
11. R.H.W. Funk, J. Höper, P. Dramm and A. Hofer, Electronic light microscopy combined with spectroscopy allows real-time analysis of structures at the subcellular level, Physiol. Meas. 19 (1998), 225-233.
12. A. Cossariza, M. Baccarani-Contri, G. Kalashnikova and C. Franceschi, A new method for the cytofluorimetric analysis of mitochondrial membrane potential using the J-aggregate forming lipophilic cation 5,5,6,6-tetrachloro-1, 1,3,3tetraethylbenzimidazolcarbocyanine iodide (JC-1), Biochem. Biophys. Res. Commun. 197 (1993), 40-45.
13. M. Reers, T.W. Smith and L.B. Chen, J-aggregate formation of a carbocyanine as a quantitative fluorescent indicator of membrane potential, Biochemistry 30 (1991), 4480-4486.
14. G. Fiskum, A. Starkov, B.M. Polster and C. Chinopoulos, Mitochondrial mechanisms of neural cell death and neuroprotective intertventions in Parkinson's disease, Ann NY Acad Sci 991 (2003), 111-119.
15. J.F. Turrens and A. Boveris, Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria, Biochem J. 191 (1980), 421-427.
16. T.S. Chan, S. Teng, J.X. Wilson, G. Galati, S. Khan and P.J. O'Brien, Coenzyme Q cytoprotective mechanism for mitochondrial complex I cytopathies involves NAD(P)H:Quinone oxidoreductase 1 (NQ01), Free Rad. Res. 36 (2002), 421-427.
17. 10 therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke like episodes, Acta. Neurol. Scand. 83 (1991), 356-359.
18. 10 therapy for a mitochondrial encephalopathy with cytochrome c oxidase deficiency. A 31 P NMR study, Neurology 39 (1989), 399-403.
19. 10 deficiency, Lancet 356 (2000), 391-395.
20. 10 in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes (MELAS): Evaluation by noninvasive tissue oximetry, J. Neurol. Sci. 162 (1999), 65-68.
21. L. van Maldergem, F. Trijbels, S. DiMauro, P.J. Sindelar, O. Musimeci, A. Jansen, X. Delberghe, J. Martin and Y. Gillerot, Coenzyme Q- responsive Leigh's encephalopathy in two sisters, Ann. Neurol. 52 (2002), 750-754.
22. 10 with multiple vitamins is generally ineffective in treatment of mitochondrial disease, Neurology 43 (1993), 884-890.
23. N. Bresolin, C. Doriguzzi, C. Concetto, C. Angelici, I. Moroni, E. Castelli, E. Cossutta, A. Binda, A. Gallanti, S. Gabellino, G. Piccolo, A. Martinuzzi, E. Ciafaloni, E. Arnaudo, L. Liciardello, A. Carenci and G. Scarlato, Ubidecarenone in the treatment of mitochondrial myopathies: a multicenter double blind trial, J. Neurol. Sci. 100 (1990), 70-78.
24. 10 in plasma and erythrocytes: comparison of antioxidant levels in healthy probands after oral supplementation and in patients suffering from sickle cell anemia, Clin. Chim. Acta 326 (2002), 155-161.